Effects of age and gender on the cardiovascular responses to isoproterenol

J Gerontol A Biol Sci Med Sci. 1999 Sep;54(9):B393-400; discussion B401-3. doi: 10.1093/gerona/54.9.b393.

Abstract

We studied the effects of age and gender on cardiovascular responses to beta-adrenergic stimulation with the use of two-dimensional echocardiography in 16 young (aged 20-31) and 20 older (aged 60-75) healthy individuals. Following administration of atropine, each subject was given an infusion of isoproterenol at incremental doses from 0.010 to 0.030 microgram kg-1 min-1. The slopes of the fractional shortening-end-systolic wall stress (FS-sigma es) relationships were steeper in the young men (-0.87 +/- 0.28, n = 8) compared to the older men (-0.41 +/- 0.13, n = 10), and in the young women (-0.55 +/- 0.14, n = 8) compared to the older women (-0.38 +/- 0.13, n = 10). Furthermore, the magnitude of the age-associated differences in these slopes was larger in the men (old vs young) than in the women (old vs young) which, in the absence of changes in preload, suggests a greater decline in the contractile response to isoproterenol with advancing age in men compared to women. Furthermore, the men exhibited a greater attenuation of chronotropic response to isoproterenol than did the women. These observations suggest that gender plays a significant role in the age-associated decline in inotropic and chronotropic responses to beta-adrenergic stimulation, with men exhibiting a greater decline with aging than women.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenergic beta-Agonists / pharmacology*
  • Adult
  • Aged
  • Aging / physiology*
  • Cardiovascular System / drug effects*
  • Female
  • Humans
  • Isoproterenol / pharmacology*
  • Male
  • Middle Aged
  • Muscarinic Agonists / pharmacology
  • Myocardial Contraction / drug effects
  • Sex Characteristics*
  • Ventricular Function, Left / drug effects

Substances

  • Adrenergic beta-Agonists
  • Muscarinic Agonists
  • Isoproterenol